BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

919 related articles for article (PubMed ID: 31522588)

  • 1. Circ_0015756 promotes proliferation, invasion and migration by microRNA-7-dependent inhibition of FAK in hepatocellular carcinoma.
    Liu L; Yang X; Li NF; Lin L; Luo H
    Cell Cycle; 2019 Nov; 18(21):2939-2953. PubMed ID: 31522588
    [No Abstract]   [Full Text] [Related]  

  • 2. MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity.
    Xu L; Beckebaum S; Iacob S; Wu G; Kaiser GM; Radtke A; Liu C; Kabar I; Schmidt HH; Zhang X; Lu M; Cicinnati VR
    J Hepatol; 2014 Mar; 60(3):590-8. PubMed ID: 24211739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circular RNA hsa_circ_103809 suppresses hepatocellular carcinoma proliferation and invasion by sponging miR-620.
    Li X; Shen M
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(2):555-566. PubMed ID: 30720163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated expression of circular RNA circ_0008450 predicts dismal prognosis in hepatocellular carcinoma and regulates cell proliferation, apoptosis, and invasion via sponging miR-548p.
    Zhang J; Chang Y; Xu L; Qin L
    J Cell Biochem; 2019 Jun; 120(6):9487-9494. PubMed ID: 30556306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of hsa_circ_0074854 Suppresses the Migration and Invasion in Hepatocellular Carcinoma via Interacting with HuR and via Suppressing Exosomes-Mediated Macrophage M2 Polarization.
    Wang Y; Gao R; Li J; Tang S; Li S; Tong Q; Li S
    Int J Nanomedicine; 2021; 16():2803-2818. PubMed ID: 33880025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-6875-3p promotes the proliferation, invasion and metastasis of hepatocellular carcinoma via BTG2/FAK/Akt pathway.
    Xie Y; Du J; Liu Z; Zhang D; Yao X; Yang Y
    J Exp Clin Cancer Res; 2019 Jan; 38(1):7. PubMed ID: 30621734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hsa_circ_0079875 functions as a competitive endogenous RNA to promote hepatocellular carcinoma progression.
    Liu Y; Luo X; Chen W; Dong Z; Cheng T; Chen L; Ju L; Cai W; Bian Z
    Cell Cycle; 2024 Mar; 23(5):519-536. PubMed ID: 38684479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway.
    Fu X; Wen H; Jing L; Yang Y; Wang W; Liang X; Nan K; Yao Y; Tian T
    Cancer Sci; 2017 Apr; 108(4):620-631. PubMed ID: 28132399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CircRNA circ_0067934 promotes tumor growth and metastasis in hepatocellular carcinoma through regulation of miR-1324/FZD5/Wnt/β-catenin axis.
    Zhu Q; Lu G; Luo Z; Gui F; Wu J; Zhang D; Ni Y
    Biochem Biophys Res Commun; 2018 Mar; 497(2):626-632. PubMed ID: 29458020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway.
    Wang R; Yu Z; Chen F; Xu H; Shen S; Chen W; Chen L; Su Q; Zhang L; Bi J; Zeng W; Li W; Huang X; Wang Q
    Biomed Pharmacother; 2018 Jul; 103():1632-1642. PubMed ID: 29864952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circ_0027791 contributes to the growth and immune evasion of hepatocellular carcinoma via the miR-496/programmed cell death ligand 1 axis in an m6A-dependent manner.
    Yu F; Fang P; Fang Y; Chen D
    Environ Toxicol; 2024 Jun; 39(6):3721-3733. PubMed ID: 38546290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circular RNA hsa_circ_0000673 promotes hepatocellular carcinoma malignance by decreasing miR-767-3p targeting SET.
    Jiang W; Wen D; Gong L; Wang Y; Liu Z; Yin F
    Biochem Biophys Res Commun; 2018 Jun; 500(2):211-216. PubMed ID: 29627570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The competing endogenous circular RNA ADAMTS14 suppressed hepatocellular carcinoma progression through regulating microRNA-572/regulator of calcineurin 1.
    Song C; Li D; Liu H; Sun H; Liu Z; Zhang L; Hu Y
    J Cell Physiol; 2019 Mar; 234(3):2460-2470. PubMed ID: 30317540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hsa_circ_0008092 Contributes to Cell Proliferation and Metastasis in Hepatocellular Carcinoma via the miR-502-5p/CCND1 Axis.
    Maimaiti Y; Kamali A; Yang P; Zhong K; Abuduhadeer X
    Protein Pept Lett; 2022; 29(7):595-604. PubMed ID: 35899951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circular RNA hsa_circ_0005239 contributes to hepatocellular carcinoma cell migration, invasion, and angiogenesis by targeting the miR-34a-5p/PD-L1 axis.
    He T; Huang J; Liang H; Zhong B; Xu G; Zhu X
    Cell Biol Int; 2023 Sep; 47(9):1519-1534. PubMed ID: 37208963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hsa_circ_0001806 promotes glycolysis and cell progression in hepatocellular carcinoma through miR-125b/HK2.
    Chen X; She P; Wang C; Shi L; Zhang T; Wang Y; Li H; Qian L; Li M
    J Clin Lab Anal; 2021 Dec; 35(12):e23991. PubMed ID: 34664737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo and in vitro effects of microRNA-221 on hepatocellular carcinoma development and progression through the JAK-STAT3 signaling pathway by targeting SOCS3.
    Huang S; Zhou D; Li YX; Ming ZY; Li KZ; Wu GB; Chen C; Zhao YN
    J Cell Physiol; 2019 Apr; 234(4):3500-3514. PubMed ID: 30370582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hsa_circ_101280 promotes hepatocellular carcinoma by regulating miR-375/JAK2.
    Cao S; Wang G; Wang J; Li C; Zhang L
    Immunol Cell Biol; 2019 Feb; 97(2):218-228. PubMed ID: 30302825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA DBH-AS1 facilitates the tumorigenesis of hepatocellular carcinoma by targeting miR-138 via FAK/Src/ERK pathway.
    Bao J; Chen X; Hou Y; Kang G; Li Q; Xu Y
    Biomed Pharmacother; 2018 Nov; 107():824-833. PubMed ID: 30142544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-379-5p inhibits tumor invasion and metastasis by targeting FAK/AKT signaling in hepatocellular carcinoma.
    Chen JS; Li HS; Huang JQ; Dong SH; Huang ZJ; Yi W; Zhan GF; Feng JT; Sun JC; Huang XH
    Cancer Lett; 2016 May; 375(1):73-83. PubMed ID: 26944318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.